Is Inflammation from Common Medications Tied to Pancreatic Cancer?
Inflammation resulting from use of commonly prescribed mediations does not increase risk of pancreatic cancer, according to a study published in Cancer Epidemiology.
Chronic pancreatitis...
Hem/Onc Roundup: Experts Discuss Phase 2 Trial of NSCLC Treatment, and More
Is Myeloma Development Associated With Blood Type?
ABO blood groups may play a role in the development and outcomes of multiple myeloma, according to new...
Opioid Use May Be Linked to Pancreatic Cancer
The use of opioids may increase an individual’s risk of developing pancreatic cancer, according to a new study published in PLOS ONE.
Researchers from the...
Hem/Onc Roundup: Similar Risk Factors for Racial Disparity in Cancer and COVID-19, and More
Risk Factors for Racial Disparities Are Similar for Cancer and COVID-19
Factors that lead to racial disparities in cancer, including health comorbidities, education level, and...
Some Pancreatic Cancer Patients May Develop Diabetes After Surgery
A study found that surgery for pancreatic cancer was associated with the development of postoperative diabetes, although newly-diagnosed diabetes had high odds of resolution following...
Metabolic Health is a Risk Factor for Pancreatic Cancer, Regardless of Obesity
Metabolic health may be a risk factor for the development of pancreatic cancer, independent of obesity, according to a study published in Cancer Epidemiology,...
Hem/Onc Roundup: Lung Cancer Screenings Decline, Insurance Status Linked to Myeloma Survival, and More
Study: Lung Cancer Screening Amid the COVID-19 Pandemic
A review found a decline in lung cancer screening, but an overall rise in malignancies since the COVID-19...
